Renal effects of adenosine 3′,5′-cyclic monophosphate and dibutyryl adenosine 3′,5′-cyclic monophosphate

Open Access
Publisher Website
Google Scholar
Abstract
Stable water diuresis was produced in anesthetized, hydrocortisone-treated hypophysectomized dogs by infusion of 2.5% dextrose. Infusion of adenosine 3′,5′-cyclic monophosphate (cyclic AMP) in the left renal artery decreased ipsilaterally glomerular filtration rate (GFR), cortical and non-cortical renal plasma flow, and tended to increase urine flow (V) and free-water clearance (CH2O) despite a decrease in mean arterial pressure. Infusion of dibutyryl adenosine 3′,5′-cyclic monophosphate (dibutyryl cyclic AMP) in the left renal artery increased V and CH2O significantly (PH2O and the change in sodium excretion was trivial. Cyclic AMP probably produced its effects on renal hemodynamics and mean arterial pressure wholly or in part through the action of metabolites such as 5′-AMP and adenosine on the renal and systemic vasculature. The absence of an effect of dibutyryl cyclic AMP on renal hemodynamics and its bilateral effect may be explained by the resistance of this nucleotide derivative to metabolism. Dibutyryl cyclic AMP appears to decrease by direct cellular effect(s) proximal tubular sodium reabsorption but does not prevent virtually complete reabsorption of the increased load of sodium in the distal nephron. This effect on the kidney is qualitatively and quantitatively similar to the effect of renal arterial infusion of isoproterenol. The results suggest that synthesis of cyclic AMP in proximal renal tubule cells in response to stimulation of beta adrenergic or other receptors can mediate a decrease in the proximal tubular reabsorption of sodium.